Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Disulfiram
Drug ID BADD_D00695
Description A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms (acetaldehyde syndrome). It acts by inhibiting aldehyde dehydrogenase.
Indications and Usage For the treatment and management of chronic alcoholism
Marketing Status Prescription; Discontinued
ATC Code N07BB01; P03AA04
DrugBank ID DB00822
KEGG ID D00131
MeSH ID D004221
PubChem ID 3117
TTD Drug ID D0X5SD
NDC Product Code 64980-172; 65571-0005; 0054-0356; 62135-431; 51927-3121; 42794-028; 60429-196; 62135-432; 42973-137; 72643-028; 38779-1971; 71052-221; 0054-0357; 51927-0188; 73309-150; 64980-171; 47781-607
Synonyms Disulfiram | Bis(diethylthiocarbamoyl) Disulfide | Tetraethylthioperoxydicarbonic Diamide, ((H2N)C(S))2S2 | Tetraethylthiuram Disulfide | Disulfide, Tetraethylthiuram | Antabus | Antabuse | Teturam | Dicupral | Esperal | Alcophobin | Anticol
Chemical Information
Molecular Formula C10H20N2S4
CAS Registry Number 97-77-8
SMILES CCN(CC)C(=S)SSC(=S)N(CC)CC
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Brain injuryDopamine beta-hydroxylaseP09172T749372742552; 681921; 7416268; 2224697; 1503145; 476222; 9072070; 881586; 11938582; 345861; 6732388; 3537906; 8947325; 15709459
DyspnoeasAldehyde dehydrogenase family 1 member A3P47895Not Available3761172; 6368395; 12209194; 11803702; 4043765; 12724782; 6391543; 7141984; 1685418
Motor dysfunctionAldehyde dehydrogenase family 1 member A3P47895Not Available3761172; 6368395; 12209194; 11803702; 4043765; 12724782; 6391543; 7141984; 1685418
SedationAldehyde dehydrogenase family 1 member A3P47895Not Available3761172; 6368395; 12209194; 11803702; 4043765; 12724782; 6391543; 7141984; 1685418
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Alanine aminotransferase increased13.03.01.0030.017310%
Alcohol intolerance14.02.01.0010.025965%
Alcoholism19.07.02.0010.025965%Not Available
Anxiety19.06.02.0020.025965%
Aspartate aminotransferase increased13.03.01.0060.025965%
Asthenia08.01.01.0010.017310%Not Available
Breath odour07.01.06.002--Not Available
Catatonia19.11.01.0010.017310%Not Available
Delusion19.10.01.0010.034620%
Depression19.15.01.0010.025965%
Dermatitis acneiform23.02.01.004--
Dermatitis allergic23.03.04.003; 10.01.03.014--Not Available
Dermatitis atopic10.01.04.004; 23.03.04.016--Not Available
Diarrhoea07.02.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dysgeusia17.02.07.003; 07.14.03.001--
Encephalopathy17.13.02.0010.034620%
Eye pain06.08.03.002--
Fatigue08.01.01.0020.025965%
Gait disturbance17.02.05.016; 08.01.02.0020.017310%
Generalised tonic-clonic seizure17.12.01.0020.069240%Not Available
Headache17.14.01.0010.043275%
Hepatic failure09.01.03.002--
Hepatic necrosis09.01.07.002--
Hepatitis09.01.07.004--Not Available
Hepatitis fulminant11.07.01.003; 09.01.07.007--Not Available
Hepatomegaly09.01.05.0010.025965%Not Available
Hypertension24.08.02.0010.043275%
Hypoaesthesia17.02.06.023--Not Available
The 1th Page    1 2 3    Next   Last    Total 3 Pages